Cargando…
Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
Increasing numbers of biomarkers have been identified in various cancers. However, biomarkers associated with endometrial carcinoma (EC) remain largely to be explored. In the current research, we downloaded the RNA-seq data and corresponding clinicopathological features from the Cancer Genome Atlas...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171931/ https://www.ncbi.nlm.nih.gov/pubmed/34095226 http://dx.doi.org/10.3389/fmolb.2021.670893 |
_version_ | 1783702446233616384 |
---|---|
author | Liu, Jinhui Xu, Mengting Wu, Zhipeng Yang, Yan Yuan, Shuning Liang, Jianqiang Zhu, Hongjun |
author_facet | Liu, Jinhui Xu, Mengting Wu, Zhipeng Yang, Yan Yuan, Shuning Liang, Jianqiang Zhu, Hongjun |
author_sort | Liu, Jinhui |
collection | PubMed |
description | Increasing numbers of biomarkers have been identified in various cancers. However, biomarkers associated with endometrial carcinoma (EC) remain largely to be explored. In the current research, we downloaded the RNA-seq data and corresponding clinicopathological features from the Cancer Genome Atlas (TCGA) database. We conducted an expression analysis, which resulted in RILPL2 as a novel diagnostic biomarker in EC. The dysregulation of RILPL2 in EC was also validated in multiple datasets. The correlations between clinical features and RILPL2 expression were assessed by logistic regression analysis. Then, Kaplan-Meier analysis, univariate and multivariate Cox regression analysis were performed to estimate prognostic values of RILPL2 in the TCGA cohort, which revealed that increased level of RILPL2 was remarkably associated with better prognosis and could act as an independent prognostic biomarker in patients with EC. Moreover, correlation analysis of RILPL2 and tumor-infiltrating immune cells (TIICs) indicated that RILPL2 might play a critical role in regulating immune cell infiltration in EC and is related to immune response. Besides, high methylation level was a significant cause of low RILPL2 expression in EC. Subsequently, weighted gene co-expression network analysis (WGCNA) and enrichment analysis were conducted to explore the RILPL2-involved underlying oncogenic mechanisms, and the results indicated that RILPL2 mainly regulated cell cycle. In conclusion, our findings provided evidence that downregulation of RILPL2 in EC is an indicator of adverse prognosis and RILPL2 may act as a promising target for the therapeutics of EC. |
format | Online Article Text |
id | pubmed-8171931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81719312021-06-03 Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma Liu, Jinhui Xu, Mengting Wu, Zhipeng Yang, Yan Yuan, Shuning Liang, Jianqiang Zhu, Hongjun Front Mol Biosci Molecular Biosciences Increasing numbers of biomarkers have been identified in various cancers. However, biomarkers associated with endometrial carcinoma (EC) remain largely to be explored. In the current research, we downloaded the RNA-seq data and corresponding clinicopathological features from the Cancer Genome Atlas (TCGA) database. We conducted an expression analysis, which resulted in RILPL2 as a novel diagnostic biomarker in EC. The dysregulation of RILPL2 in EC was also validated in multiple datasets. The correlations between clinical features and RILPL2 expression were assessed by logistic regression analysis. Then, Kaplan-Meier analysis, univariate and multivariate Cox regression analysis were performed to estimate prognostic values of RILPL2 in the TCGA cohort, which revealed that increased level of RILPL2 was remarkably associated with better prognosis and could act as an independent prognostic biomarker in patients with EC. Moreover, correlation analysis of RILPL2 and tumor-infiltrating immune cells (TIICs) indicated that RILPL2 might play a critical role in regulating immune cell infiltration in EC and is related to immune response. Besides, high methylation level was a significant cause of low RILPL2 expression in EC. Subsequently, weighted gene co-expression network analysis (WGCNA) and enrichment analysis were conducted to explore the RILPL2-involved underlying oncogenic mechanisms, and the results indicated that RILPL2 mainly regulated cell cycle. In conclusion, our findings provided evidence that downregulation of RILPL2 in EC is an indicator of adverse prognosis and RILPL2 may act as a promising target for the therapeutics of EC. Frontiers Media S.A. 2021-05-19 /pmc/articles/PMC8171931/ /pubmed/34095226 http://dx.doi.org/10.3389/fmolb.2021.670893 Text en Copyright © 2021 Liu, Xu, Wu, Yang, Yuan, Liang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Liu, Jinhui Xu, Mengting Wu, Zhipeng Yang, Yan Yuan, Shuning Liang, Jianqiang Zhu, Hongjun Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title | Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title_full | Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title_fullStr | Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title_full_unstemmed | Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title_short | Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma |
title_sort | low expression of rilpl2 predicts poor prognosis and correlates with immune infiltration in endometrial carcinoma |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171931/ https://www.ncbi.nlm.nih.gov/pubmed/34095226 http://dx.doi.org/10.3389/fmolb.2021.670893 |
work_keys_str_mv | AT liujinhui lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT xumengting lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT wuzhipeng lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT yangyan lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT yuanshuning lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT liangjianqiang lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma AT zhuhongjun lowexpressionofrilpl2predictspoorprognosisandcorrelateswithimmuneinfiltrationinendometrialcarcinoma |